Assessing Leukocyte-endothelial Interactions Under Flow Conditions in an Ex Vivo Autoperfused Microflow Chamber Assay
December 30th, 2014
9.3K views
Here, we present a protocol that allows the investigator to assess leukocyte recruitment dynamics ex vivo by connecting a chamber coated with endothelial-derived adhesion molecules to the circulatory system of a mouse. This method offers significant advantages since it allows for leukocyte assessment under relative biological conditions.
Overview
This article presents a protocol for assessing leukocyte recruitment dynamics ex vivo using a microflow chamber connected to a mouse's circulatory system. The method allows for real-time observation of leukocyte interactions with endothelial adhesion molecules under physiological flow conditions.
Key Study Components
Area of Science
- Neuroscience
- Immunology
- Vascular Biology
Background
- Leukocyte recruitment is crucial for immune responses.
- Understanding leukocyte-endothelial interactions can inform therapeutic strategies.
- Existing techniques may not accurately replicate physiological conditions.
- This protocol aims to address those limitations.
Purpose of Study
- To develop a method for real-time assessment of leukocyte dynamics.
- To evaluate the effects of treatments on leukocyte behavior.
- To enhance understanding of leukocyte interactions under flow conditions.
Methods Used
- Coating a glass chamber with endothelial adhesion molecules.
- Connecting the chamber to the mouse's circulatory system.
- Infusing blood and recording leukocyte interactions.
- Analyzing rolling velocity and displacement of leukocytes.
Main Results
- Real-time visualization of leukocyte interactions was achieved.
- Leukocyte rolling velocity and displacement were quantified.
- The method demonstrated advantages over traditional techniques.
- Physiological flow conditions were successfully maintained.
Conclusions
- This protocol provides a reliable method for studying leukocyte dynamics.
- It can be applied to various treatments affecting leukocyte behavior.
- The technique enhances our understanding of immune responses.
Frequently Asked Questions
What is the main advantage of this protocol?
The protocol allows for assessment of leukocyte interactions under physiological flow conditions, which is not possible with traditional methods.
How are the leukocyte interactions recorded?
Leukocyte interactions are recorded in real-time using a microscope connected to the microflow chamber.
What types of treatments can be evaluated using this method?
The method can evaluate various treatments that may affect leukocyte behavior, such as pharmacological agents.
Is this method applicable to other animal models?
While this protocol is designed for mice, it may be adapted for other animal models with appropriate modifications.
What are the key components needed for this experiment?
Key components include a microflow chamber, endothelial adhesion molecules, and surgical tools for connecting to the mouse.
How long does the experiment take?
The setup and recording process can be completed within a few hours, depending on the specific experimental design.
Executive Industry Relevance
Studying leukocyte-endothelial interactions under physiological flow conditions is critical for de-risking inflammatory disease targets and validating mechanistic hypotheses in early discovery. This ex vivo autoperfused microflow chamber assay enables real-time quantification of leukocyte rolling velocity, providing predictive confidence in target validation and supporting go/no-go decisions in preclinical programs. By preserving native leukocyte function and avoiding ex vivo manipulation artifacts, the method enhances translational continuity from discovery through preclinical validation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by assessing functional expression of leukocyte adhesion molecules under physiologic shear stress.
- Operational Value: Enables biological de-risking through direct measurement of leukocyte rolling velocity as a functional readout of adhesion molecule activity.
- Predictive Value: Supports portfolio triage by quantifying target engagement and mechanistic effects of immunomodulatory compounds in a disease-relevant system.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream screening by establishing baseline leukocyte interaction profiles under controlled flow.
- Operational Value: Delivers standardized, reproducible quantitative outputs (rolling velocity, displacement) enabling reliable compound evaluation across campaigns.
- Scalability: Facilitates platform reuse for testing multiple adhesion molecules or therapeutic candidates in a consistent physiological environment.
Translational & Preclinical Research
- Scientific Value: Maintains disease relevance by using native peripheral blood leukocytes from anesthetized mice, preserving in vivo-like cellular states.
- Operational Value: Provides continuity from discovery to preclinical validation by measuring functional outputs directly translatable to intravital microscopy endpoints.
- Risk Mitigation: Informs risk-adjusted advancement decisions by identifying compounds that alter leukocyte-endothelial interactions under flow before costly in vivo studies.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from target validation through lead identification, enabling mechanistic de-risking prior to phenotypic screening or preclinical efficacy studies.
- Discovery Biology: Supports hypothesis testing and pathway clarification by quantifying leukocyte adhesion dynamics under physiological flow, reducing mechanistic ambiguity.
- Screening: Delivers assay readiness through standardized chamber coating and flow stabilization, ensuring reproducible leukocyte interaction measurements.
- Analytics: Generates quantitative readouts (rolling velocity, displacement) via ImageJ analysis, enabling objective comparison of treatment effects across experimental conditions.
- Translational Research: Connects to preclinical continuity by using native leukocyte populations, preserving physiological relevance for extrapolation to in vivo inflammation models.
- Enterprise Reuse: Functions as a reusable capability for screening multiple targets or compounds, reducing redundant model development and enhancing workflow efficiency.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by measuring functional leukocyte behavior under shear stress, reducing false positives from static assays.
- Operational Value: Ensures standardization and reproducibility through controlled flow conditions (30 mmHg) and real-time imaging, minimizing inter-experiment variability.
- Strategic Value: Improves go/no-go decisions by providing early mechanistic insights, reducing late-stage biological risk in inflammatory disease programs.
- Portfolio Impact: Enables risk-adjusted prioritization by quantifying target modulation effects, supporting data-driven advancement decisions in immunomodulatory pipelines.
Implementation Considerations
- Requires expertise in microsurgery, intravital microscopy, and hemodynamic pressure regulation to maintain stable ex vivo arteriovenous circuits.
- Depends on specialized instrumentation including a pressure transducer, Harvard Apparatus flow regulator, and water immersion objective for leukocyte visualization.
- Necessitates cross-team standardization of chamber coating protocols, tubing preparation, and heparinization procedures to ensure consistent physiological flow.
- Involves adaptation considerations when testing different endothelial adhesion molecules or leukocyte subtypes, requiring validation of coating efficiency and specificity.
- Practical limitations include the technical complexity of surgical vessel cannulation and the need for anesthesia-maintained murine models, which may constrain throughput.
Biopharma FAQs
Why does measuring leukocyte rolling velocity matter for target validation?
Leukocyte rolling velocity is a direct functional readout of endothelial adhesion molecule activity under physiological flow, enabling quantitative assessment of target engagement and mechanistic effects of immunomodulatory treatments in a disease-relevant system.
How does isolating the independent variable (adhesion molecule coating) support discovery pipeline decisions?
By coating the microflow chamber with specific endothelial adhesion molecules, researchers isolate the variable of interest to assess its direct impact on leukocyte interactions, enabling clear mechanistic interpretation and target de-risking.
What do quantitative dependent variable measurements (rolling velocity, displacement) enable in preclinical programs?
Quantitative measurements of leukocyte rolling velocity and displacement provide objective, reproducible data to compare treatment effects, establish dose-response relationships, and inform go/no-go decisions based on functional target modulation.
Why are replication requirements important for cross-functional collaboration in inflammation research?
Replication under standardized flow conditions (30 mmHg) and consistent chamber preparation ensures data comparability across teams and sites, supporting reliable target validation and reducing variability in mechanistic conclusions.
What statistical analysis capabilities are required before implementing this assay in a discovery workflow?
The assay requires basic statistical comparison of leukocyte rolling velocity and displacement between control and treatment groups using tools like ImageJ for measurement and standard software (e.g., GraphPad) for analysis, enabling detection of significant changes in adhesion molecule function.
